TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Uroderma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
954
|
1,055
|
958 |
| Financial expenses |
0
|
1
|
0 |
| Earnings before taxes |
405
|
497
|
490 |
| EBITDA |
417
|
516
|
511 |
| Total assets |
955
|
924
|
882 |
| Current assets |
459
|
397
|
410 |
| Current liabilities |
79
|
77
|
162 |
| Equity capital |
876
|
847
|
720 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
5
|
3
|
3 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
91.7%
|
91.7%
|
81.6% |
| Turnover per employee |
191
|
352
|
319 |
| Profit as a percentage of turnover |
42.5%
|
47.1%
|
51.1% |
| Return on assets (ROA) |
42.4%
|
53.9%
|
55.6% |
| Current ratio |
581.0%
|
515.6%
|
253.1% |
| Return on equity (ROE) |
46.2%
|
58.7%
|
68.1% |
| Change turnover |
-65
|
94
|
140 |
| Change turnover % |
-6%
|
10%
|
17% |
| Chg. No. of employees |
2
|
0
|
0 |
| Chg. No. of employees % |
67%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.